Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Breast 2

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Sarcopenia 1Muscle Weakness 1Motor Activity 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Creatine × 1 year × Clear all
NCT06112990 2026-06-03

CREATINE-52

University of Utah

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT07463092 2026-04-08

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

University of Sao Paulo

Phase NA Recruiting
34 enrolled
Genitourinary

Prostatic Neoplasms, Sarcopenia

NCT07372144 2026-01-28

IARA

D'Or Institute for Research and Education

Phase 3 Not yet recruiting
227 enrolled
Breast

Breast Neoplasms

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡